Archana Kotha
Overview
Explore the profile of Archana Kotha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knight D, Bruno K, Singh A, Munipalli B, Gajarawala S, Solomon M, et al.
Front Cardiovasc Med
. 2024 Apr;
11:1332508.
PMID: 38562189
Background: Defective connective tissue structure may cause individuals with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD) to develop cardiac defects. Methods: We conducted a retrospective chart review of...
2.
Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders
Menton S, Fairweather D, Bruno K, Thompson C, Candelo E, Darakjian A, et al.
Laryngoscope
. 2023 Aug;
134(2):773-778.
PMID: 37597175
Objective: The aim was to study laryngological complaints in patients with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD). Methods: A total of 363 patients met inclusion for the...
3.
Fairweather D, Bruno K, Darakjian A, Bruce B, Gehin J, Kotha A, et al.
Front Med (Lausanne)
. 2023 May;
10:1096180.
PMID: 37181352
Background: Joint pain is a common symptom in patients with hypermobile Ehlers-Danlos Syndrome (hEDS), hypermobility spectrum disorders (HSD) and fibromyalgia. The goal of this study was to determine whether symptoms...
4.
Knight D, Confiado S, Bruno K, Fairweather D, Seymour-Sonnier A, Jain A, et al.
SN Compr Clin Med
. 2022 Jul;
4(1):138.
PMID: 35811641
In a large academic medical center, patient requests from the community and internal referrals for evaluation of suspected hypermobility conditions were being denied consultation because services specific to this condition...
5.
Norton N, Bruno K, Di Florio D, Whelan E, Hill A, Morales-Lara A, et al.
Front Cardiovasc Med
. 2022 Jan;
8:757784.
PMID: 35096991
Doxorubicin is a widely used and effective chemotherapy, but the major limiting side effect is cardiomyopathy which in some patients leads to congestive heart failure. Genetic variants in have been...